Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patient re-classification?
Richard John BryantBob YangYiannis PhilippouKarla LamMaureen ObiakorJennifer AyersVirginia ChiocchiaFergus GleesonRuth MacPhersonClare VerrillPrasanna SooriakumaranFreddie C HamdySimon F BrewsterPublished in: BJU international (2018)
Replacing a systematic PB with mpMRI ±TB as part of an AS protocol increased the likelihood of re-classifying patients on AS and identifying men with clinically significant disease requiring treatment. mpMRI ±TB as part of AS thereby represents a significant advance in the oncological safety of the AS protocol.
Keyphrases
- prostate cancer
- magnetic resonance imaging
- randomized controlled trial
- radical prostatectomy
- end stage renal disease
- mycobacterium tuberculosis
- newly diagnosed
- chronic kidney disease
- computed tomography
- deep learning
- peritoneal dialysis
- heavy metals
- magnetic resonance
- benign prostatic hyperplasia
- risk assessment
- combination therapy
- patient reported
- minimally invasive
- diffusion weighted imaging